T
TCRX
Tscan Therapeutics, Inc.
0.7430
-0.0127-1.68%After Hours: 0.7486 +0.0056 +0.75%19:34 07/31 EDT
OPEN/PREV CLOSE0.7542/0.7632
TODAY RANGE0.7542-0.7848
VOL26.15K
MARKET CAP50.65M
52 WEEK RANGE0.7160-2.570
AVG VOL (3M)679.47K
% TURNOVER0.04%
TURNOVER--
P/E (TTM)-0.8095
% RANGE4.01%
EPS(TTM)-0.9574
P/E(FORWARD)-0.8857
P/B0.4806
BVPS1.613
DIVIDEND--
P/S4.270
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP47.24M
SHARES OUTSTANDING65.35M
NEXT EARNINGS08/10-08/14
FREE FLOAT60.95M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·07/29 11:52
TScan Therapeutics doses first patient in ALLOHA-2 trial
TipRanks·07/22 16:31
TScan’s TSC-101 Trial: A New Cell Therapy Bet in Transplant Oncology
Dow Jones·06/23 12:30
TScan Therapeutics Price Target Maintained With a $5.00/Share by Wedbush
Benzinga·06/23 12:20
Wedbush Reiterates Outperform on TScan Therapeutics, Maintains $5 Price Target
Dow Jones·06/23 11:52
TScan Therapeutics Price Target Maintained With a $6.00/Share by Needham
Benzinga·06/23 11:43
Needham Reiterates Buy on TScan Therapeutics, Maintains $6 Price Target
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.